Volume 15, Number 4—April 2009
The Amazon Region
Acute Conjunctivitis with Episcleritis and Anterior Uveitis Linked to Adiaspiromycosis and Freshwater Sponges, Amazon Region, Brazil, 2005
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians. Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at http://www.medscape.com/cme/eid; (4) view/print certificate.
Upon completion of this activity, participants will be able to:
- Describe the mechanism of infection for adiaspiromycosis.
- Identify the age group most susceptible to ocular adiaspiromycosis.
- Describe presenting symptoms associated with ocular adiaspiromycosis.
- Describe the frequency of ocular lesions associated with adiaspiromycosis.
- Identify risk factors for ocular adiaspiromycosis.
Beverly Merritt, Technical Writer-Editor, Emerging Infectious Diseases. Disclosure: Beverly Merritt has disclosed no relevant financial relationships.
Désirée Lie, MD, MSEd, Clinical Professor, Family Medicine, University of California, Orange; Director, Division of Faculty Development, UCI Medical Center, Orange, California. Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.
Disclosures: Tatiana M. Lanzieri, MD, MSc, has disclosed that she has been employed by GlaxoSmithKline since April 2008, but this study was conducted while she was working in the Brazilian Ministry of Health. Márcia O. Mendes, BSc, MSc; Mario A.P. Moraes, MD; Ernesto I.M. Renoiner, ND; Marta H.P. Dantas, ND, MSc; Carlos F. Fonseca, MD; Expedito J.A. Luna, MD; and Douglas L. Hatch, MD, MPH, have disclosed no relevant financial relationships.